HS
Therapeutic Areas
AIVITA Biomedical Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AV-GBM-1 | Glioblastoma | Phase 2/3 |
| AV-MEL-1 | Melanoma | Phase 1B |
| Multi-Pathogen Vaccine Kit | Prevention of multiple infections (SARS-CoV-2, Influenza, HPV, etc.) | Pre-clinical/Development |
| Drug | Indication | Phase |
|---|---|---|
| AV-GBM-1 | Glioblastoma | Phase 2/3 |
| AV-MEL-1 | Melanoma | Phase 1B |
| Multi-Pathogen Vaccine Kit | Prevention of multiple infections (SARS-CoV-2, Influenza, HPV, etc.) | Pre-clinical/Development |